Имплантация аппарата
вспомогательного
кровообращения АВК-N 
Москва
Искусственное сердце Поиск 10М
Осевые насосы
Defined Indications for Durable VADs
Bridge to Transplant* – Inserted for short to intermediate term support in patients actively
listed for transplant
Destination Therapy* – Inserted with the
intention of long term support
in patients 
who are not transplant candidates
Bridge to Recovery – Inserted for short term
support in a condition that is anticipate to
reverse
Bridge to Decision – Inserted for support 
when ultimate therapy is not able to be 
determined at the time of implantation
*only designation currently recognized by regulatory/payor community
U.S. Destination Therapy VAD Implants
U.S. Destination Therapy Implants
Sources: (1) Lietz-Miller papers; (2) clinical trial enrollment reporting from Thoratec, HeartWare, and Ventracor; (3) INTERMACS; and
(4) estimates of HeartMate II DT commercial utilization in 2010-11
3,200 |
|
|
|
|
3,000 |
|
|
|
|
2,800 |
|
|
|
|
2,600 |
|
|
|
|
2,400 |
|
|
|
|
2,200 |
|
|
|
|
2,000 |
|
|
|
|
1,800 |
|
|
|
|
1,600 |
|
|
|
|
1,400 |
|
|
|
|
1,200 |
|
|
|
|
1,000 |
|
|
|
|
800 |
|
|
|
|
600 |
|
|
|
|
400 |
|
|
|
|
200 |
|
|
|
|
0 |
|
|
|
|
2007 |
2008 |
2009 |
2010 |
2011 |
US VAD |
Transplants |
|
|
|
